The official blog of the Lung Institute.

What is My Why? Amy Welling

18 Apr 2018
| Under Featured | Posted by

A featured series where Lung Institute employees tell their stories #WhatIsMyWhy

My dad had lung cancer, and he passed away 10 years ago. He was a heavy smoker throughout his life, and being able to help the patients and families who have gone through the same things we did to try to help my dad has made me a big advocate for what we do at the Lung Institute.

I originally chose the Lung Institute because I was looking for a career change, and it looked like an interesting opportunity. After meeting with the executive team, it sounded like a good fit for what I wanted to do.

I started as the lead office manager in the Pittsburgh clinic and helped with the expansion and training of other office managers throughout our clinics across the country. In the beginning of 2017, I moved down to our corporate headquarters in Tampa and continued as lead office manager here, and then I moved into being in project management and human resources.

Getting to Know the Patients

It’s been interesting, because when I started at the Lung Institute Pittsburgh clinic, it was just opening. I got to know different patients and build relationships with them. I saw how they wanted to tell their family and friends and acquaintances about us and got to hear their personal stories. I love meeting people who are able to get back to doing the things they couldn’t anymore and seeing them thrive. I get to see them breathe easier.

It’s inspirational to work for a company that’s consistently helping people improve their lifestyles. Getting to see that first hand makes such an impact and makes me want to reach out to as many people as possible, whether it’s in a clinic or on the back end in a corporate setting.

The biggest thing I love about the Lung Institute is the fact that they’re actually trying to do something to improve these patients’ lives and not just telling them what to expect from this lung condition and giving them medication. They’re able to actually breathe better instead of just waiting for the end. I’ve heard lot of patients say that, based on that they knew about what to expect from COPD and what their doctors told them, they wanted to see what other professionals had to say. They found us on the way, and we were able to give them hope.

In my time with the Lung Institute, I have gained a lot of insight into the fact that there are so many patients being affected by lung disease. It’s interesting that there’s still so much pushback from the medical community, and I hope to be able to see treatments like ours evolve and be something that all medical professionals are looking to in the future to help their patients.


* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.